Molecular Pathogenesis of Sporadic Colorectal Cancers

Overview

Journal Chin J Cancer

Publisher Biomed Central

Specialty Oncology

Date 2016 Jan 8

PMID 26738600

Citations 69

Authors

Hidetsugu Yamagishi

Hajime Kuroda

Yasuo Imai

Hideyuki Hiraishi

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) results from the progressive accumulation of genetic and epigenetic alterations that lead to the transformation of normal colonic mucosa to adenocarcinoma. Approximately 75% of CRCs are sporadic and occur in people without genetic predisposition or family history of CRC. During the past two decades, sporadic CRCs were classified into three major groups according to frequently altered/mutated genes. These genes have been identified by linkage analyses of cancer-prone families and by individual mutation analyses of candidate genes selected on the basis of functional data. In the first half of this review, we describe the genetic pathways of sporadic CRCs and their clinicopathologic features. Recently, large-scale genome analyses have detected many infrequently mutated genes as well as a small number of frequently mutated genes. These infrequently mutated genes are likely described in a limited number of pathways. Gene-oriented models of CRC progression are being replaced by pathway-oriented models. In the second half of this review, we summarize the present knowledge of this research field and discuss its prospects.

Citing Articles

Clinical Validation of a Machine Learning-Based Biomarker Signature to Predict Response to Cytotoxic Chemotherapy Alone or Combined with Targeted Therapy in Metastatic Colorectal Cancer Patients: A Study Protocol and Review.

Pagano D, Barresi V, Tropea A, Galvano A, Bazan V, Caldarella A Life (Basel). 2025; 15(2).

PMID: 40003728 PMC: 11857289. DOI: 10.3390/life15020320.

The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+ and CD8+) on Chemotherapy Response in Colorectal Cancer Patients.

Lukman K, Septianto R, Rudiman R, Ruchimat T, Sribudiani Y, Nugraha P Cancer Manag Res. 2025; 17:197-209.

PMID: 39906521 PMC: 11792878. DOI: 10.2147/CMAR.S503985.

Cold-pressed extraction of perilla seed oil enriched with alpha-linolenic acid mitigates tumour progression and restores gut microbial homeostasis in the AOM/DSS mice model of colitis-associated colorectal cancer.

Korsirikoon C, Techaniyom P, Kettawan A, Rungruang T, Metheetrairut C, Prombutara P PLoS One. 2024; 19(12):e0315172.

PMID: 39652552 PMC: 11627366. DOI: 10.1371/journal.pone.0315172.

Synthetic free fatty acid receptor (FFAR) 2 agonist 4-CMTB and FFAR4 agonist GSK13764 inhibit colon cancer cell growth and migration and regulate FFARs expression in in vitro and in vivo models of colorectal cancer.

Binienda A, Owczarek K, Salaga M, Fichna J Pharmacol Rep. 2024; 76(6):1403-1414.

PMID: 39432182 PMC: 11582145. DOI: 10.1007/s43440-024-00667-5.

Molecular Complexity of Colorectal Cancer: Pathways, Biomarkers, and Therapeutic Strategies.

Yang Z, Wang X, Zhou H, Jiang M, Wang J, Sui B Cancer Manag Res. 2024; 16:1389-1403.

PMID: 39403607 PMC: 11472760. DOI: 10.2147/CMAR.S481656.

References

Jenkins M, Hayashi S, OShea A, Burgart L, Smyrk T, Shimizu D . Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 2007; 133(1):48-56. PMC: 2933045. DOI: 10.1053/j.gastro.2007.04.044. View

van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B . Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut. 2002; 51(6):797-802. PMC: 1773491. DOI: 10.1136/gut.51.6.797. View

Yoshitaka T, Matsubara N, Ikeda M, Tanino M, Hanafusa H, Tanaka N . Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability. Biochem Biophys Res Commun. 1996; 227(2):553-7. DOI: 10.1006/bbrc.1996.1544. View

Fu B, Yachida S, Morgan R, Zhong Y, Montgomery E, Iacobuzio-Donahue C . Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol. 2012; 138(3):356-66. PMC: 3556914. DOI: 10.1309/AJCPVT7LC4CRPZSK. View

Pino M, Chung D . The chromosomal instability pathway in colon cancer. Gastroenterology. 2010; 138(6):2059-72. PMC: 4243705. DOI: 10.1053/j.gastro.2009.12.065. View

Smith G, Carey F, Beattie J, Wilkie M, Lightfoot T, Coxhead J . Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A. 2002; 99(14):9433-8. PMC: 123158. DOI: 10.1073/pnas.122612899. View

Barault L, Charon-Barra C, Jooste V, Vega M, Martin L, Roignot P . Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res. 2008; 68(20):8541-6. DOI: 10.1158/0008-5472.CAN-08-1171. View

Toyota M, Ahuja N, Herman J, Baylin S, Issa J . CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999; 96(15):8681-6. PMC: 17576. DOI: 10.1073/pnas.96.15.8681. View

Leary R, Lin J, Cummins J, Boca S, Wood L, Parsons D . Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci U S A. 2008; 105(42):16224-9. PMC: 2571022. DOI: 10.1073/pnas.0808041105. View

10.

Issa J, Shen L, Toyota M . CIMP, at last. Gastroenterology. 2005; 129(3):1121-4. DOI: 10.1053/j.gastro.2005.07.040. View

11.

Kim H, Jen J, Vogelstein B, Hamilton S . Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol. 1994; 145(1):148-56. PMC: 1887287. View

12.

Grady W, Carethers J . Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008; 135(4):1079-99. PMC: 2866182. DOI: 10.1053/j.gastro.2008.07.076. View

13.

Yamamoto H, Sawai H, Perucho M . Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res. 1997; 57(19):4420-6. View

14.

Yashiro M, Carethers J, Laghi L, Saito K, Slezak P, Jaramillo E . Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res. 2001; 61(6):2676-83. View

15.

Boland C, Thibodeau S, Hamilton S, Sidransky D, Eshleman J, Burt R . A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998; 58(22):5248-57. View

16.

Boland C, Komarova N, Goel A . Chromosomal instability and cancer: not just one CINgle mechanism. Gut. 2009; 58(2):163-4. PMC: 2858054. DOI: 10.1136/gut.2008.160143. View

17.

Minamoto T, Sawaguchi K, Mai M, Yamashita N, Sugimura T, Esumi H . Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res. 1994; 54(11):2841-4. View

18.

Souza R, Appel R, Yin J, Wang S, Smolinski K, Abraham J . Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet. 1996; 14(3):255-7. DOI: 10.1038/ng1196-255. View

19.

White R . Tumor suppressing pathways. Cell. 1998; 92(5):591-2. DOI: 10.1016/s0092-8674(00)81124-1. View

20.

Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y . Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A. 2007; 104(47):18654-9. PMC: 2141832. DOI: 10.1073/pnas.0704652104. View